{"title":"从毒瘾到21世纪的药物","authors":"M.-S. Doutre","doi":"10.1016/j.allerg.2008.01.032","DOIUrl":null,"url":null,"abstract":"<div><p>New drugs, especially biotherapies, are increasingly used for a rapidly expanding number of inflammatory and neoplastic diseases. Among these treatments, cytokines, monoclonal antibodies, anti-TNF, inhibitors of tyrosine kinase, inhibitors of epidermal growth factors receptors can induce adverse cutaneous effects. These patients need early and appropriate dermatological management. Other new drugs, such as voriconazole, lamotrigine, bupropion… are also a possible cause of skin reactions.</p></div>","PeriodicalId":92953,"journal":{"name":"Revue francaise d'allergologie et d'immunologie clinique","volume":"48 3","pages":"Pages 227-231"},"PeriodicalIF":0.0000,"publicationDate":"2008-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.allerg.2008.01.032","citationCount":"3","resultStr":"{\"title\":\"Toxidermies aux médicaments du xxie siècle\",\"authors\":\"M.-S. Doutre\",\"doi\":\"10.1016/j.allerg.2008.01.032\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>New drugs, especially biotherapies, are increasingly used for a rapidly expanding number of inflammatory and neoplastic diseases. Among these treatments, cytokines, monoclonal antibodies, anti-TNF, inhibitors of tyrosine kinase, inhibitors of epidermal growth factors receptors can induce adverse cutaneous effects. These patients need early and appropriate dermatological management. Other new drugs, such as voriconazole, lamotrigine, bupropion… are also a possible cause of skin reactions.</p></div>\",\"PeriodicalId\":92953,\"journal\":{\"name\":\"Revue francaise d'allergologie et d'immunologie clinique\",\"volume\":\"48 3\",\"pages\":\"Pages 227-231\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2008-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/j.allerg.2008.01.032\",\"citationCount\":\"3\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Revue francaise d'allergologie et d'immunologie clinique\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0335745708000580\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revue francaise d'allergologie et d'immunologie clinique","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0335745708000580","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
New drugs, especially biotherapies, are increasingly used for a rapidly expanding number of inflammatory and neoplastic diseases. Among these treatments, cytokines, monoclonal antibodies, anti-TNF, inhibitors of tyrosine kinase, inhibitors of epidermal growth factors receptors can induce adverse cutaneous effects. These patients need early and appropriate dermatological management. Other new drugs, such as voriconazole, lamotrigine, bupropion… are also a possible cause of skin reactions.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
